Download - Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive

Transcript
Page 1: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive

©2017 Health Delegates. All Rights Reserved.

November 2017Top 20 Specialty Pipeline Report

Page 2: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive

©2017 Health Delegates. All Rights Reserved.

Page 3: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive

©2017 Health Delegates. All Rights Reserved.

Page 4: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive

©2017 Health Delegates. All Rights Reserved.

Page 5: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive

©2017 Health Delegates. All Rights Reserved.

December 2017Top 20 Specialty Pipeline Report

Page 6: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive

©2017 Health Delegates. All Rights Reserved.

Page 7: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive

©2017 Health Delegates. All Rights Reserved.

Page 8: Top 20 Specialty Pipeline Report - Health Delegates...Chimeric antigen receptor T-cell therapy (CAR-T therapy) for the treatment of patients with relapsed or refractory aggressive

©2017 Health Delegates. All Rights Reserved.